Yamaguchi Junna, Tanaka Tetsuhiro, Nangaku Masaomi
Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, 113-0033, Japan.
F1000Res. 2015 Nov 4;4. doi: 10.12688/f1000research.6970.1. eCollection 2015.
Chronic kidney disease (CKD) is defined as any condition that causes reduced kidney function over a period of time. Fibrosis, tubular atrophy and interstitial inflammation are the hallmark of pathological features in CKD. Regardless of initial insult, CKD has some common pathways leading CKD to end-stage kidney disease, including hypoxia in the tubulointerstitium and proteinuria. Recent advances in genome editing technologies and stem cell research give great insights to understand the pathogenesis of CKD, including identifications of the origins of renal myofibroblasts and tubular epithelial cells upon injury. Environmental factors such as hypoxia, oxidative stress, and epigenetic factors in relation to CKD are also discussed.
慢性肾脏病(CKD)被定义为在一段时间内导致肾功能下降的任何病症。纤维化、肾小管萎缩和间质炎症是CKD病理特征的标志。无论初始损伤如何,CKD都有一些导致其发展为终末期肾病的共同途径,包括肾小管间质缺氧和蛋白尿。基因组编辑技术和干细胞研究的最新进展为理解CKD的发病机制提供了深刻见解,包括识别损伤后肾肌成纤维细胞和肾小管上皮细胞的起源。还讨论了与CKD相关的环境因素,如缺氧、氧化应激和表观遗传因素。